Indo Amines Ltd Valuation Shifts to Very Attractive Amid Market Volatility

Valuation Metrics Reveal Compelling Investment Case

As of 30 June 2026, Indo Amines trades at a P/E ratio of 12.26, a figure that stands out as highly competitive when juxtaposed with its peer group. The company’s P/BV ratio is 2.48, further underscoring its favourable valuation stance. These metrics have contributed to the company’s valuation grade being upgraded from “attractive” to “very attractive” by market analysts, reflecting a more compelling entry point for investors seeking exposure to the specialty chemicals industry.

In comparison, peers such as Sanstar and Stallion India are trading at P/E multiples of 70.25 and 47.53 respectively, while Titan Biotech commands a P/E of 55.02. This stark contrast highlights Indo Amines’ relative undervaluation, especially given its robust return on equity (ROE) of 20.22% and return on capital employed (ROCE) of 14.91%, which are indicative of efficient capital utilisation and profitability.

Enterprise Value Multiples Support Valuation Thesis

Further reinforcing the valuation appeal, Indo Amines’ enterprise value to EBITDA (EV/EBITDA) ratio stands at 10.26, markedly lower than many of its competitors. For instance, Stallion India and Titan Biotech report EV/EBITDA multiples of 29.09 and 42.68 respectively, suggesting that Indo Amines is trading at a discount on an operational earnings basis. The EV to EBIT ratio of 12.44 and EV to capital employed ratio of 1.85 also point to a valuation that is attractive relative to the company’s earnings and asset base.

PEG Ratio Indicates Growth at a Reasonable Price

Indo Amines’ PEG ratio of 0.33 is particularly noteworthy. This low PEG ratio implies that the company’s price is undervalued relative to its earnings growth potential, a factor that often appeals to growth-oriented investors. The PEG ratio compares favourably against peers, many of whom have PEG ratios at or above 1.0, signalling that Indo Amines offers growth prospects at a more reasonable price.

Stock Performance in Context of Market and Sector

Despite a day’s decline of 2.72%, Indo Amines has delivered a mixed performance over various time horizons. Year-to-date, the stock has gained 3.92%, outperforming the Sensex which is down 9.96% over the same period. However, over the past year, Indo Amines has underperformed with a negative return of 16.46% compared to the Sensex’s 8.72% decline. Longer-term returns paint a more favourable picture, with the stock delivering a 59.43% gain over five years and an extraordinary 449.18% over ten years, significantly outpacing the Sensex’s 46.01% and 186.94% respectively.

Price Range and Trading Activity

The stock currently trades at ₹134.00, down from the previous close of ₹137.75. It has a 52-week high of ₹176.00 and a low of ₹82.00, indicating a wide trading range and potential for volatility. Today’s intraday range between ₹130.90 and ₹139.85 suggests some buying interest near current levels, possibly reflecting investor recognition of the improved valuation metrics.

Micro-Cap Status and Market Perception

Indo Amines is classified as a micro-cap stock, which often entails higher risk but also greater potential for outsized returns. The company’s Mojo Score has improved to 67.0, with the Mojo Grade upgraded from Sell to Hold as of 26 May 2026. This upgrade reflects a more balanced risk-reward profile, supported by the valuation improvements and steady operational metrics.

Dividend Yield and Profitability Metrics

The dividend yield remains modest at 0.37%, which is typical for a growth-oriented specialty chemicals company reinvesting earnings into expansion. The company’s ROCE of 14.91% and ROE of 20.22% are healthy indicators of profitability and capital efficiency, reinforcing the investment case despite the relatively low dividend payout.

Peer Comparison Highlights Indo Amines’ Relative Value

When compared with peers in the specialty chemicals sector, Indo Amines stands out for its valuation attractiveness. Companies such as I G Petrochems and Indo Borax & Chemicals trade at P/E multiples of 627.41 and 29.04 respectively, while Indo Amines remains at a modest 12.26. Even companies rated as “attractive” like Gulshan Polyols (P/E 27.96) and Oriental Aromatics (P/E 319.61) are priced significantly higher. This valuation gap suggests that Indo Amines may be undervalued relative to its sector, presenting a potential opportunity for value investors.

Outlook and Investor Considerations

Indo Amines’ improved valuation metrics, combined with solid profitability and a reasonable growth outlook, suggest that the stock is positioned attractively for investors seeking exposure to the specialty chemicals sector at a micro-cap level. The company’s PEG ratio of 0.33 indicates that earnings growth is not fully priced in, offering potential upside if growth materialises as expected.

However, investors should weigh the stock’s recent volatility and underperformance over the past year against its longer-term outperformance. The micro-cap status also implies liquidity and risk considerations that may not suit all portfolios. The current Mojo Grade of Hold reflects this balanced view, signalling that while valuation is compelling, caution remains warranted.

Overall, Indo Amines presents a nuanced investment opportunity where valuation improvements have materially enhanced price attractiveness, but investors should remain vigilant to sector dynamics and company-specific developments.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →